Enjoy fast, free delivery, exclusive deals, and award-winning movies & TV shows with Prime
Try Prime and start saving today with fast, free delivery

Paperback
$56.18

$56.18 with 19 percent savings

List Price: $69.00

FREE Returns

FREE delivery Friday, May 10. Order within 17 hrs 44 mins

Select delivery location

In Stock

$$56.18 () Includes selected options. Includes initial monthly payment and selected options. Details

Ships from

Amazon.com

Ships from

Amazon.com

Sold by

Amazon.com

Sold by

Amazon.com

Returns

Eligible for Return, Refund or Replacement within 30 days of receipt

Returns

Eligible for Return, Refund or Replacement within 30 days of receipt

This item can be returned in its original condition for a full refund or replacement within 30 days of receipt.

Read full return policy

Payment

Secure transaction

Payment

Secure transaction

We work hard to protect your security and privacy. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others. Learn more

Details

Add a gift receipt for easy returns

Other sellers on Amazon

New & Used (21) from $54.99 & FREE Shipping.

Follow the author

Name: Clinical Laboratory Medicine for Mental Health Professionals: 9781615370849: Medicine & Health Science Books @ Amazon.com
Price: 56.18 USD
Availability: InStock
Rating: 4.7 (70 reviews)

Sandra A. Jacobson

Follow

Clinical Laboratory Medicine for Mental Health Professionals 1st Edition

by M.D. Sandra A. Jacobson (Author)

4.7 70 ratings

See all formats and editions

{"desktop_buybox_group_1":[{"displayPrice":"$56.18","priceAmount":56.18,"currencySymbol":"$","integerValue":"56","decimalSeparator":".","fractionalValue":"18","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":true,"offerListingId":"uMDUtOJkeKtCDHBopNE8ApMpL6lkgNfIt4ztXA8LhoXuKOBJ8TVFW7zZAFG%2BVFeTeM%2FFuk7RGbTNJ8y16BpLphyVRFz9LiIm7fLd8AjsyqrZaaZAd4sPZYuh5eioxMplrZCxaHZAQDiLbm8azt1UDw%3D%3D","locale":"en-US","buyingOptionType":"NEW","aapiBuyingOptionIndex":0}]}

Purchase options and add-ons

A revised, abridged version of the seminal work, Laboratory Medicine in Psychiatry and Behavioral Science, Clinical Laboratory Medicine for Mental Health Professionals more directly addresses the needs of general psychiatrists and their mental health colleagues in clinical practice.

Sections on laboratory tests, diseases and conditions, and psychotropic medications include alphabetically arranged entries, making it easy for busy clinicians to reference the updated information. For each laboratory test, the following information is provided: - The type of test (e.g., blood, urine, etc.)- An explanation of the test- The test's relevance to psychiatry- Patient preparation- Medical and psychiatric indications for the test- Numerical reference ranges- Critical values for test results- The potential meaning of abnormal results (e.g., factors that lead to increased or decreased levels)- Interfering factors- Cross-references to other tests or conditions

Information on clinical diagnosis and laboratory testing is provided for diseases and conditions, and psychotropic medications are examined from both a screening and a monitoring standpoint. This reference includes an appendix featuring therapeutic and toxic psychotropic drug levels, a quick guide to ECG interpretation, and figures to help clarify complex processes underlying laboratory test results, such as abnormal liver function tests in hepatotoxic and cholestatic drug reactions, elevations in conjugated vs. unconjugated bilirubin, and the basis of osmolality and sodium abnormalities in the syndrome of inappropriate ADH secretion.

Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals the definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

ISBN-10

9781615370849
ISBN-13

978-1615370849
Edition

1st
Publisher

Amer Psychiatric Pub
Publication date

December 12, 2016
Language

English
Dimensions

7 x 0.8 x 10 inches
Print length

388 pages
See all details

Frequently bought together

Clinical Laboratory Medicine for Mental Health Professionals

$56.18

Get it as soon as Friday, May 10

In Stock

Ships from and sold by Amazon.com.

+

Managing the Side Effects of Psychotropic Medications

$65.22

Get it as soon as Friday, May 10

In Stock

Ships from and sold by Amazon.com.

+

Psychopharmacology Algorithms: Clinical Guidance from the Psychopharmacology Algorithm Project at the Harvard South Shore Psy

$71.78

Get it as soon as Friday, May 10

In Stock

Sold by ayvax and ships from Amazon Fulfillment.

Total price:

To see our price, add these items to your cart.

Try again!

Details

Added to Cart

These items are shipped from and sold by different sellers.

Show details Hide details

Choose items to buy together.

Joseph F. Goldberg
135
Paperback
32 offers from $60.82
Robert Boland
345
Paperback
24 offers from $117.63
John Preston Psy.D. ABPP
928
Paperback
in Medical Psychopharmacology
6 offers from $18.00
DANIEL J. CARLAT
20
Paperback
31 offers from $63.40
Stephen M. Stahl
1,261
Paperback
30 offers from $59.45
Kathleen Wheeler PhD PMHNP-BC APRN FAAN
338
Paperback
23 offers from $98.10

Editorial Reviews

Review

With a focus on the needs of general psychiatrists and their mental health colleagues in clinical practice, Clinical Laboratory Medicine for Mental Health Professionals is a revised, abridged version of the seminal work, Laboratory Medicine in Psychiatry and Behavioral Science.

Updated information on laboratory tests, diseases and conditions, and psychotropic medications is arranged alphabetically and presented in a tabular format, making it easy for busy clinicians to find needed information. This reference includes an appendix featuring therapeutic and toxic psychotropic drug levels, a quick guide to ECG interpretation, and figures to help clarify complex processes underlying laboratory test results, such as abnormal liver function tests in hepatotoxic and cholestatic drug reactions, elevations in conjugated vs. unconjugated bilirubin, and the basis of osmolality and sodium abnormalities in the syndrome of inappropriate ADH secretion.

Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals a definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

--From the Inside Flap

With a focus on the needs of general psychiatrists and their mental health colleagues in clinical practice, Clinical Laboratory Medicine for Mental Health Professionals is a revised, abridged version of the seminal work, Laboratory Medicine in Psychiatry and Behavioral Science.

Updated information on laboratory tests, diseases and conditions, and psychotropic medications is arranged alphabetically and presented in a tabular format, making it easy for busy clinicians to find needed information. This reference includes an appendix featuring therapeutic and toxic psychotropic drug levels, a quick guide to ECG interpretation, and figures to help clarify complex processes underlying laboratory test results, such as abnormal liver function tests in hepatotoxic and cholestatic drug reactions, elevations in conjugated vs. unconjugated bilirubin, and the basis of osmolality and sodium abnormalities in the syndrome of inappropriate ADH secretion.

Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals a definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

--From the Back Cover

Dr. Jacobson has provided an excellent and practical reference for mental health professionals that encompasses the majority of laboratory tests and other tests (e.g. EEG, PET, MSLT) one either needs to consider or encounters during the care of psychiatric patients. The chapter organization by individual test, as well as by specific psychiatric disorder and psychiatric medication, make it easy to use and something a clinician can quickly turn to in daily practice. The information provided is clearly written and easy to grasp such that both trainee or seasoned clinician can benefit from this book. --Catherine Crone, M.D., FAPA, FACP, FAPM, Associate Professor of Psychiatry, George Washington University School of Medicine, Clinical Professor of Psychiatry, Virginia Commonwealth University School of Medicine

From the Inside Flap

With a focus on the needs of general psychiatrists and their mental health colleagues in clinical practice, Clinical Laboratory Medicine for Mental Health Professionals is a revised, abridged version of the seminal work, Laboratory Medicine in Psychiatry and Behavioral Science.

Updated information on laboratory tests, diseases and conditions, and psychotropic medications is arranged alphabetically and presented in a tabular format, making it easy for busy clinicians to find needed information. This reference includes an appendix featuring therapeutic and toxic psychotropic drug levels, a quick guide to ECG interpretation, and figures to help clarify complex processes underlying laboratory test results, such as abnormal liver function tests in hepatotoxic and cholestatic drug reactions, elevations in conjugated vs. unconjugated bilirubin, and the basis of osmolality and sodium abnormalities in the syndrome of inappropriate ADH secretion.

Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals a definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

Product details

ASIN ‏ : ‎ 1615370846
Publisher ‏ : ‎ Amer Psychiatric Pub; 1st edition (December 12, 2016)
Language ‏ : ‎ English
Paperback ‏ : ‎ 388 pages
ISBN-10 ‏ : ‎ 9781615370849
ISBN-13 ‏ : ‎ 978-1615370849
Item Weight ‏ : ‎ 1.53 pounds
Dimensions ‏ : ‎ 7 x 0.8 x 10 inches

Best Sellers Rank: #52,036 in Books (See Top 100 in Books)
- #10 in Psychiatry (Books)
- #707 in Unknown

Customer Reviews:
4.7 70 ratings

Brief content visible, double tap to read full content.

Full content visible, double tap to read brief content.

Videos

Help others learn more about this product by uploading a video!

Upload your video

About the author

Follow authors to get new release updates, plus improved recommendations.

Sandra A. Jacobson

Brief content visible, double tap to read full content.

Full content visible, double tap to read brief content.

Dr. Jacobson is a neuropsychiatrist and medical writer with more than 25 years of experience in clinical care and research devoted to various aging issues, including brain fitness, depression, delirium/confusional states, Alzheimer's disease and other dementias, and anxiety disorders. I have particular interests in medications used to treat elders and in the use of clinical laboratory tests to assist diagnosis and treatment of disease.

Research Publications

Leuchter AF, Jacobson SA. Quantitative measurement of brain electrical activity in delirium. International psychogeriatrics / IPA 1991;3:231-47.

Fogelson D, Jacobson S, Sternbach H. A retrospective study of valproate in a private psychiatric practice. Annals of Clinical Psychiatry 1991;3:315-320.

Lock J, Kleis B, Strouse T, Jacobson S, Yager J, Servis M. The role and function of residents' organizations in psychiatry education. Academic Psychiatry 1993;17:26-31.

Jacobson SA, Leuchter AF, Walter DO. Conventional and quantitative EEG in the diagnosis of delirium among the elderly. Journal of neurology, neurosurgery, and psychiatry 1993;56:153-8.

Jacobson SA, Leuchter AF, Walter DO, et al. Serial quantitative EEG among elderly subjects with delirium. Biological psychiatry 1993;34:135-40.

Ross BD, Jacobson SA, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-463.

Holzer JC, Jacobson SA, Folstein MF. Treating compulsive self-mutilation in a mentally retarded patient. The American journal of psychiatry 1996;153:133.

Jacobson S, Schreibman B. Behavioral and pharmacologic treatment of delirium. American Family Physician 1997;56:2005-2012.

Jacobson SA. Delirium in the elderly. The Psychiatric clinics of North America 1997;20:91-110.

Boutros NN, Jacobson SA, Campbell D. Role of the unquantified electroencephalography in psychiatric research. CNS spectrums 1999;4:60-3.

Jacobson S, Jerrier H. EEG in delirium. Seminars in Clinical Neuropsychiatry 2000;5:86-92.

Jacobson S. Psychopharmacology in hepatic and renal failure (a CME article). Psychiatric Times 2002 Nov XIX:65-69.

Jacobson SA, Folstein MF. Psychiatric perspectives on headache and facial pain. Otolaryngologic clinics of North America 2003;36:1187-200.

Jacobson SA, Dwyer PC, Machan JT, Carskadon MA. Quantitative analysis of rest-activity patterns in elderly postoperative patients with delirium: support for a theory of pathologic wakefulness. Journal of Clinical Sleep Medicine 2008;4:137-42.

Jacobson SA, Sabbagh MN. Donepezil: potential neuroprotective and disease-modifying effects. Expert Opinion on Drug Metabolism & Toxicology 2008;4:1363-9.

Ignatov I, Belden C, Jacobson S, et al. Possible Alzheimer's disease in an apolipoprotein E2 homozygote. Journal of Alzheimer's disease 2009;16:35-8.

Lue LF, Walker DG, Jacobson S, Sabbagh M. Receptor for advanced glycation end products: its role in Alzheimer’s disease and other neurological diseases. Future Neurology 2009; 4:167-177.

Cole L, Belden C, Jacobson S, Liebsack C, Myers K, Reninger C, Berk C, Sabbagh MN. Probable early-onset Alzheimer's disease in an apolipoprotein E2 homozygote. Dement Geriatr Cogn Disord 2010; 30:387-391.

Sabbagh MN, Malek-Ahmadi M, Kataria R, Belden CM, Connor DJ, Pearson C, Jacobson S, Yaari R, Singh U. The Alzheimer's questionnaire: a proof of concept study for a new informant-based dementia assessment. J Alzheimers Dis 2010; 22:1015-1021.

Adler CH, Hentz JG, Shill HA, Sabbagh MN, Driver-Dunckley E, Evidente VG, Jacobson SA, Beach TG, Boeve B, Caviness JN. Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. Parkinsonism & Related Disorders 2011;17:456-8.

Damian AM, Jacobson SA, Hentz JG, et al. The Montreal Cognitive Assessment and the Mini-mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dementia and Geriatric Cognitive Disorders 2011;31:126-31.

Jacobson SA, Sabbagh MN. Investigational drugs for the treatment of AD: what can we learn from negative trials? Alzheimer's Research & Therapy 2011;3:14.

Sabbagh MN, Fleisher A, Chen K, Rogers J, Berk C, Reiman E, Pontecorvo M, Mintun M, Skovronsky D, Jacobson SA, Sue LI, Liebsack C, Charney AS, Cole L, Belden C, Beach TG. Positron emission tomography and neuropathologic estimates of fibrillar amyloid-beta in a patient with Down syndrome and Alzheimer disease. Archives of Neurology 2011;68:1461-6.

Cabral D, Beach TG, Vedders L, Sue LI, Jacobson S, Myers K, Sabbagh MN. Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimer's & Dementia 2011;7:509-13.

Malek-Ahmadi M, Davis K, Belden C, Laizure B, Jacobson S, Yaari R, Singh U, Sabbagh MN. Validation and diagnostic accuracy of the Alzheimer's questionnaire. Age Ageing 2012;41:396-9.

Malek-Ahmadi M, Davis K, Belden CM, Jacobson S, Sabbagh MN. Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment. BMC Geriatrics 2012;12:3.

Decourt B, Walker A, Gonzales A, Malek-Ahmadi M, Liebsack C, Davis KJ, Belden CM, Jacobson SA, Sabbagh MN. Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study. Platelets 2013;24:235-8.

Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, Ahlskog JE, Caselli RJ, Jacobson S, Sabbagh M, Adler C, Woodruff B, Beach TG, Iranzo A, Gelpi E, Santamaria J, Tolosa E, Singer C, Mash DC, Luca C, Arnulf I, Duyckaerts C, Schenck CH, Mahowald MW, Dauvilliers Y, Graff-Radford NR, Wszolek ZK, Parisi JE, Dugger B, Murray ME, Dickson DW. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 2013;14:754-62.

Maarouf CL, Beach TG, Adler CH, Malek-Ahmadi M, Kokjohn TA, Dugger BN, Walker DG, Shill HA, Jacobson SA, Sabbagh MN, Roher AE; Arizona Parkinson’s Disease Consortium. Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology. Biomarker Insights 2013;8:19-28.

Jacobson S. Laboratory testing in the diagnosis of Alzheimer’s disease: an update. Psychiatric News Update 2013:2(40):1-3.

Jacobson S. Effects of pharmacokinetic and pharmacodynamic changes in the elderly (a CME article). Psychiatric Times 2013 Jan:26-29.

Sabbagh MN, Malek-Ahmadi M, Dugger BN, Lee K, Sue LI, Serrano G, Walker DG, Davis K, Jacobson SA, Beach TG. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease. BMC Neurology 2013;13:44.

Kokjohn TA, Maarouf CL, Daugs ID, Hunter JM, Whiteside CM, Malek-Ahmadi M, Rodriguez E, Kalback W, Jacobson SA, Sabbagh MN, Beach TG, Roher AE. Neurochemical profile of dementia pugilistica. Journal of Neurotrauma 2013;30:981-97.

Malek-Ahmadi M, Kahlon V, Adler CA, Obradov A, Thind K, Shill HA, Sue LI, Caviness JN, Jacobson S, Sabbagh MN. Prevalence of hippocampal sclerosis in a clinicopathologically characterized cohort. Clin Exp Med Sci 2013;1:317-27.

Henderson-Smith A, Chow D, Meechoovet B, Aziz M, Jacobson SA, Shill HA, Sabbagh MN, Caviness JN, Adler CH, Driver-Dunckley ED, Beach TG, Yin H, Dunckley T. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening. PLoS One. 2013 Oct 30;8(10):e77711.

Roher AE, Maarouf CL, Malek-Ahmadi M, Wilson J, Kokjohn TA, Daugs ID, Whiteside CM, Kalback WM, Macias MP, Jacobson SA, Sabbagh MN, Ghetti B, Beach TG. Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations. Am J Neurodegener Dis. 2013;2:187-207.

Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, Beach TG; Arizona Parkinson's Disease Consortium. Concomitant pathologies among a spectrum of parkinsonian disorders.Parkinsonism & Related Disorders 2014;20:525-9.

Shill HA, Hentz JG, Jacobson SA, Belden C, Sabbagh MN, Beach TG, Driver-Dunckley E, Adler CH. Essential Tremor in the Elderly and Risk for Dementia. J Neurodegener Dis. 2014 328765.

Symanski C, Shill HA, Dugger B, Hentz JG, Adler CH, Jacobson SA, Driver-Dunckley E, Beach TG. Essential tremor is not associated with cerebellar Purkinje cell loss. Mov Disord. 2014;29:496-500.

Dugger BN, Hentz JG, Adler CH, Sabbagh MN, Shill HA, Jacobson S, Caviness JN, Belden C, Driver-Dunckley E, Davis KJ, Sue LI, Beach TG. Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. J Neuropathol Exp Neurol. 2014;73:244-52.

Jacobson SA. Food interactions seen with many psychotropics. Psychiatric News. 2014; Vol 49 No. 13.

Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, Dugger BN. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014 Jul 29;83(5):406-12.

Maarouf CL, Kokjohn TA, Walker DG, Whiteside CM, Kalback WM, Whetzel A, Sue LI, Serrano G, Jacobson SA, Sabbagh MN, Reiman EM, Beach TG, Roher AE. Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease. PLoS One. 2014 Aug 28;9(8):e105784.

Jacobson SA, Simpson RG, Lubahn C, Hu C, Belden CM, Davis KJ, Nicholson LR, Long KE, Osredkar T, Lorton D. Characterization of fibromyalgia symptoms in patients 55-95 years old: a longitudinal study showing symptom persistence with suboptimal treatment. Aging Clin Exp Res 2015 Feb;27(1):75-82.

Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JM, Hu C, and the Arizona Parkinson’s Disease Consortium. Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations. Parkinsonism & Related Disorders 2014 Sep;20(9):1009-14.

Malek-Ahmadi M, Chen K, Davis K, Belden CM, Powell J, Jacobson, SA, Sabbagh MN. Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire. Alzheimers Res Ther. 2015; Jan 8;7(1):1.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment. BMC Neurol. 2015 Aug 20;15:146.

Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG. REM sleep behavior disorder and neuropathology in Parkinson's disease. Mov Disord. 2015 Sep;30(10):1413-7.

Sabbagh MN, Chen K, Rogers J, Fleisher AS, Liebsack C, Bandy D, Belden C, Protas H, Thiyyagura P, Liu X, Roontiva A, Luo J, Jacobson S, Malek-Ahmadi M, Powell J, Reiman EM. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia. Alzheimer’s Dement. 2015 Aug;11(8):994-1004.

Budolfson K, Malek-Ahmadi M, Belden CM, Powell J, Davis K, Jacobson S, Sabbagh MN. Neuropsychological Correlates of the Alzheimer's Questionnaire. J Alzheimer’s Dis. 2015;46(2):389-97.

Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC,Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak, SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology. 2015 Aug;35(4):354-89.

Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE. Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition. J Neuropathol Exp Neurol. 2016 Jun 12. pii: nlw047. [Epub ahead of print]

Jacobson SA. Which metabolic panel for psychiatric practice: basic or comprehensive? Psychiatric News. April 7, 2017; Vol 52 No 7.

Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG.GBA mutations in Parkinson disease: earlier death but similar neuropathological features. 2017 Nov 24(11):1363-1368.

Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH. Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study. Acta Neurol Scand. 2019 Jan;139(1):76-81.